Final Meaningful Use Objectives for

Similar documents
Final Meaningful Use Objectives for

Final Meaningful Use Objectives for 2017

EHR Incentive Programs for Eligible Professionals: What You Need to Know for 2016 Tipsheet

FINAL Meaningful Use Objectives for

Meaningful Use - Modified Stage Alternate Exclusions and/or Specifications

EHR Incentive Programs: 2015 through 2017 (Modified Stage 2) Overview

2018 Modified Stage 3 Meaningful Use Criteria for Eligible Professionals (EPs)*

Medicare and Medicaid EHR Incentive Program. Stage 3 and Modifications to Meaningful Use in 2015 through 2017 Final Rule with Comment

Meaningful Use - Modified Stage 2. Brett Paepke, OD David Wolfson Marni Anderson

Meaningful Use CHCANYS Webinar #1

MEANINGFUL USE 2015 PROPOSED 2015 MEANINGFUL USE FLEXIBILITY RULE

EHR/Meaningful Use

of 23 Meaningful Use 2015 PER THE CMS REVISION TO THE FINAL RULE RELEASED OCTOBER 6, 2015 CHARTMAKER MEDICAL SUITE

Meaningful Use What You Need to Know for December 6, 2016

Meaningful Use Virtual Office Hours Webinar for Eligible Providers and Hospitals

STAGE 2 PROPOSED REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1

Eligible Professional Attestation Worksheet for Modified Stage 2 Medicare Electronic Health Record (EHR) Incentive Program

Meaningful Use 2016 and beyond

MEANINGFUL USE STAGE 2

during the EHR reporting period.

Medicaid EHR Incentive Program What You Need to Know about Program Year 2016

Ophthalmology Meaningful Use Attestation Guide 2016 Edition Updated July 2016

Meaningful Use and PCC EHR. Tim Proctor Users Conference 2017

2015 MEANINGFUL USE STAGE 2 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Stage 1 Changes Tipsheet Last Updated: August, 2012

Appendix 4 CMS Stage 1 Meaningful Use Requirements Summary Tables 4-1 APPENDIX 4 CMS STAGE 1 MEANINGFUL USE REQUIREMENTS SUMMARY

Meaningful Use Stage 2

Stage 1 Meaningful Use Objectives and Measures

Alaska Medicaid Program

Stage 2 Eligible Professional Meaningful Use Core and Menu Measures. User Manual/Guide for Attestation using encompass 3.0

MEANINGFUL USE STAGE FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Meaningful Use Reporting period for 2017: Change: Any consecutive 90 days in 2017 for Medicaid customers only.

PROPOSED MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Stage 2 Meaningful Use Objectives and Measures

Beyond Meaningful Use: Driving Improved Quality. CHCANYS Webinar #1: December 14, 2016

CHIME Concordance Analysis of Stage 2 Meaningful Use Final Rule - Objectives & Measures

PBSI-EHR Off the Charts Meaningful Use in 2016 The Patient Engagement Stage

Advancing Care Information Measures Data Validation Criteria. Reporting Requirement: Yes/No or Numerator/Denominator

Final Meaningful Use Rules Add Short-Term Flexibility

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 2

Meaningful Use Modified Stage 2 Roadmap Eligible Hospitals

The History of Meaningful Use

THE MEANING OF MEANINGFUL USE CHANGES IN THE STAGE 2 MU FINAL RULE. Angel L. Moore, MAEd, RHIA Eastern AHEC REC

CMS Meaningful Use Proposed Rules Overview May 5, 2015

CMS EHR Incentive Programs in 2015 through 2017 Overview

2015 Meaningful Use and emipp Updates (for Eligible Professionals)

Computer Provider Order Entry (CPOE)

MIPS Program: 2018 Advancing Care Information Category

MIPS Program: 2017 Advancing Care Information Category (formerly known as Meaningful Use) Proposed Rule Guide

Core Measure Set. Status. MU1 Increase from 30% New. Computerized Physician Order Entry Use computerized provider order. NextGen EHR Medication Module

Meaningful Use: Review of Changes to Objectives and Measures in Final Rule

Medicaid EHR Incentive Program Health Information Exchange Objective Stage 3 Updated: February 2017

Practice Director Modified Stage MU Guide 03/17/2016

Meaningful Use and Care Transitions: Managing Change and Improving Quality of Care

Eligible Professionals (EP) Meaningful Use Final Objectives and Measures for Stage 1, 2011

Meaningful Use Measures: Quick Reference Guide Stage 2 (2014 and Beyond)

How to Participate Today 4/28/2015. HealthFusion.com 2015 HealthFusion, Inc. 1. Meaningful Use Stage 3: What the Future Holds

2016 MEANINGFUL USE AND 2017 CHANGES to the Medicare EHR Incentive Program for EPs. September 27, 2016 Kathy Wild, Lisa Sagwitz, and Joe Pinto

Eligible Professionals. How can the West Virginia Health Information Network (WVHIN) assist you in meeting Meaningful Use requirements?

Transforming Health Care with Health IT

APPENDIX 2 NCQA PCMH 2011 AND CMS STAGE 1 MEANINGFUL USE REQUIREMENTS

New Hampshire Guidelines for Program Year 2016: Meaningful Use and Clinical Quality Measure Supporting Documents

Meaningful Use Overview for Program Year 2017 Massachusetts Medicaid EHR Incentive Program

2017 Transition Year Flexibility Advancing Care Information (ACI) Category Options

Meaningful Use Update: Stage 3 and Beyond. Carla McCorkle, Midas+ Solutions CQM Product Lead

Welcome to the MS State Level Registry Companion Guide for

Webinar #5 Meaningful Use: Looking Ahead to Stage 2 and CPS 12

Overview of the EHR Incentive Program Stage 2 Final Rule published August, 2012

Game Plan. Meaningful Use Where are We? So is Anyone Registering? So, are EPs getting any money? $31,968,176,183

Measures Reporting for Eligible Hospitals

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 1

Agenda 2. EHR Incentive Programs 3/5/2015. Overview EHR incentive programs Meaningful Use Differences between Stage 1 and Stage 2

Medicaid Provider Incentive Program

Measures Reporting for Eligible Providers

Medicare & Medicaid EHR Incentive Programs. Stage 2 Final Rule Travis Broome AMIA

Prime Clinical Systems, Inc

EHR Meaningful Use Guide

Meaningful Use and How it Relates to the Quality Payment Program. Erin Dormaier, CHTS-IM, PCMH CCE Transformation Support Services Manager

Eligibility. Program Structure and Process for Receiving Incentives

Sevocity v Advancing Care Information User Reference Guide

Meaningful Use Modified Stage 2 Roadmap Eligible Professionals

Meaningful Use and PCC EHR

Meaningful Use Stage 2 For Eligible and Critical Access Hospitals

Qualifying for Medicare Incentive Payments with Crystal Practice Management. Version 1.0

THE ECONOMICS OF MEDICAL PRACTICE UNDER HIPAA/HITECH

ecw and NextGen MEETING MU REQUIREMENTS

American Recovery & Reinvestment Act

Copyright. Last updated: September 28, 2017 MicroMD EMR Objective Measure Calculations Manual: Performance Year 2017

2016 Meaningful Use Requirements Webinar - Transcript

Meaningful Use Basics and Attestation Process Guide for Medicare and Medi-Cal. Lori Hack & Val Tuerk, Object Health

Meaningful Use Participation Basics for the Small Provider

MACRA and MIPS. How Medicare Meaningful Use and PQRS are Changing

Oklahoma s Public Health Immunization Reporting Updates. By Brittany Curry of OSDH. An Important Reminder. For audio, you must use your phone:

REQUIREMENTS GUIDE: How to Qualify for EHR Stimulus Funds under ARRA

2014 PCMH Standards: How CPCI Can Help with Transformation. CHCANYS Quality Improvement Program November 20, 2014

Stage 3 and ACI s Relationship to Medicaid MU Massachusetts Medicaid EHR Incentive Program

HIE/HIO Organizations Supporting Meaningful Use (MU) Stage 2 Goals Q Update from 2013 HIE Survey Participants

Meaningful Use: Today and in the Future VMGMA Spring Conference Richmond, VA March 21, 2016

HIE and Meaningful Use Stage 2 Matrix

Updates to the EHR Incentive Programs Jason Felts, MS, CSCS HIT Practice Advisor

Transcription:

Final Meaningful Use Objectives All Eligible Professionals (EP) must attest to all objectives using a 2014 Edition CEHRT. Stage 2 Objective Protect Health Information Clinical Decision Support Stage 2 Objective Description Protect electronic health information created or maintained by the CEHRT through the implementation of appropriate technical capabilities. Use clinical decision support to improve performance on highpriority health conditions. Measure Amount Yes/No Stage 2 Measure(s) Exclusion(s) 2016-2017 Alternate Objective, Measure or Exclusion 2 Conduct or review a security risk analysis in accordance with the requirements in 45 CFR 164.309(a)(1), including addressing the security (to include encryption of ephi created or maintained by CEHRT in accordance with requirements in 45 CFR 164.312(a)(2)(iv) and 45 CFR 164.306(d)(3), and implement security updates as necessary and correct identified security deficiencies as part of the EP s risk management process. Measure 2 Exclusion: medication orders during the EHR 5 ea./ Yes/No Measure 1: Implement five (5) clinical decision support interventions related to four or more (4+) clinical quality measures at a relevant point in patient care for the entire EHR Absent four (4) clinical quality measures related to an EP s scope of practice or patient population, the clinical decision support interventions must be related to high-priority health conditions. Measure 2: The EP has enabled and implemented the functionality for drug-drug and drug-allergy interaction checks for the entire EHR

Computerized Provider Order Entry (CPOE) Prescribing Summary of Care Patient Specific Education Use computerized provider order entry for medication, laboratory, and radiology orders directly entered by any licensed healthcare professional who can enter orders into the medical record per state, local and professional guidelines. Generate and transmit permissible prescriptions electronically (erx). The EP who transitions their patient to another setting of care or provider of care or refers their patient to another provider of care provides a summary care record for each transition of care or referral. Use clinically relevant information from CEHRT to identify patient-specific 60%/30%/30% Measure 1: More than 60% of medication orders created by the EP or during the EHR reporting period are recorded using CPOE. Measure 2: More than 30% of laboratory orders created by the EP during the EHR reporting period are recorded using CPOE. Measure 3: More than 30% of radiology orders created by the EP during the EHR reporting period are recorded using CPOE. 50% More than 50% of all permissible prescriptions, written by the EP are queried for a drug formulary are transmitted electronically using CEHRT. 10% The EP that transitions or refers their patient to another setting of care or provider of care must- 1) Use CEHRT to create a summary of care record; and 2) electronically transmits such summary to a receiving provider for more than 10% of transitions of care and referrals. 10% Patient-specific education resources identified by CEHRT are provided to patients for more than 10% of all Measure 1 Exclusion: medication orders during the EHR Measure 2 Exclusion: laboratory orders during the EHR Measure 3 Exclusion: radiology orders during the EHR reporting Any EP who: 1. Writes fewer than 100 permissible prescriptions during the EHR reporting period; or 2. Does not have a pharmacy within his or her organization and there are no pharmacies that accept electronic prescriptions within 10 miles of the EP s practice location at the start of his or her EHR EP Exclusion: Any EP who transfers a patient to another setting or refers a patient to another provider less than 100 times during the EHR Any EP who has no office visits during the EHR Alternate Exclusion for Measure 2: Providers scheduled to be in Stage 1 in 2016 may claim an exclusion for measure 2 (laboratory orders) of the Stage 2 CPOE objective for an EHR reporting period in 2016 Alternate Exclusion for Measure 3: Providers scheduled to be in Stage 1 in 2016 may claim an exclusion for measure 3 (radiology orders) of the Stage 2 CPOE objective for an EHR reporting period in 2016

Medication Reconciliation Patient Access education resources and provide those resources to the patient. The EP that receives a patient from another setting of care or provider of care or believes an encounter is relevant performs medication reconciliation. Provide patients the ability to view online, download, and transmit their health information within four (4) business days of the information being available to the EP unique patients with office visits seen by the EP during the EHR reporting 50% The EP performs medication reconciliation for more than 50% of transitions of care in which the patient is transitioned into the care of the EP. 50%/at least 1 Measure 1: More than 50% of all unique patients seen by the EP during the EHR reporting period are provided timely access to view online, download, and transmit to a third party their health information subject to the EP s discretion to withhold certain information. Measure 2: For an EHR reporting period in 2016, at least one patient seen by the EP during the EHR reporting period (or patient-authorized representative) views, downloads or transmits to a third party his or her health information during the EHR reporting For an EHR reporting period in 2017, more than 5 percent of unique patients seen by the EP during the EHR reporting period (or his or her authorized representatives) view, download or transmit to a third party their health information during the EHR Any EP who was not the recipient of any transitions of care during the EHR Any EP who: 1. Neither orders nor creates any of the information listed for inclusion as part of the measures, or 2. Conducts 50% or more of his or her patient encounters in a county that does not have 50% or more of its housing units with 4Mbps broadband availability according to the latest information available from the FCC on the first day of the EHR reporting 2017 Any EP who: 1. Neither orders nor creates any of the information listed for inclusion as part of the measures, or 2. Conducts 50 percent or more of his or her patient encounters in a county that does not have 50 percent or more of its housing units with 4Mbps broadband availability according to the latest information available from the FCC on the first day of the EHR

Secure Messaging Use secure electronic messaging to communicate with patients on relevant health information. Yes/No For an EHR reporting period in 2016, for at least 1 patient seen by the EP during the EHR reporting period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patientauthorized representative), or in response to a secure message sent by the patient (or the patient-authorized representative) during the EHR Any EP who: 1. Has no office visits during the EHR reporting period, or 2. Any EP who conducts 50% or more of his or her patient encounters in a county that does not have 50% or more of its housing units with 4Mbps broadband availability according to the latest information available from the FCC on the first day of the EHR Public Health Registry Reporting The EP is in active engagement with a Public Health Agency (PHA) is in active engagement with a public health agency to submit electronic public health data from CEHRT except where prohibited and in accordance with applicable law and practice. For an EHR reporting period in 2017, for more than 5 percent of unique patients seen by the EP during the EHR reporting period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure message sent by the patient (or the patient-authorized representative) during the EHR 2 measures Active Engagement is 1. Completed registration to submit data, 2. Testing and validation, or 3. Production EPs may report to more than one specialized registry and may count specialized registry reporting more than once to meet the required number of measures for the objective. Measure 1 Immunization Registry Reporting: The EP is in active engagement with a PHA to submit immunization data. Measure 1 Exclusions 1. Any EP that does not administer any immunizations to any of the populations for which data is collected by the jurisdiction s immunization registry or IIS during the EHR reporting period, 2. Any EP that operates in a jurisdiction for which no immunization registry or IIS is capable of accepting the specific standards required to meet the CEHRT definition at the start of the EHR reporting period, or 3. Any EP that operates in a jurisdiction where no immunization registry or IIS has declared readiness to receive EPs must meet at least 2 measures in 2016 and 2017.

Measure 2 Syndromic Surveillance Reporting: EP is in active engagement with a PHA to submit syndromic surveillance data. Measure 3 Specialized Registry Reporting: The EP is in active engagement to submit data to a specialized registry. immunization data from the EP at the start of the EHR Measure 2 Exclusions: 1. Any EP that is not in a category of providers from which ambulatory syndromic surveillance data is collected by their jurisdiction's syndromic surveillance system; 2. Any EP that operates in a jurisdiction for which PHA is capable of receiving electronic syndromic surveillance data from EPs in the specific standards required to meet the CEHRT definition at the start of the EHR reporting period; or 3. Any EP that operates in a jurisdiction where no PHA has declared readiness to receive syndromic surveillance data from EPs at the start of the EHR Measure 3 Exclusions: 1. Any EP that does not diagnose or treat any disease or condition associated with or collect relevant data that is required by a specialized registry in their jurisdiction during the EHR reporting period; 2. Any EP that operates in a jurisdiction for which no specialized registry is capable of accepting electronic registry transactions in the specific standards required to meet the CEHRT definition at the start of the EHR reporting period; or 3. Any EP that operates in a jurisdiction where no specialized registry for which the EP, eligible hospital, or CAH is

eligible has declared readiness to receive electronic registry transactions at the beginning of the EHR reporting